Singapore markets open in 6 hours 53 minutes

PAVmed Inc. (PAVM)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.8501+0.0601 (+3.36%)
As of 01:58PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close1.7900
Open1.8200
Bid1.7700 x 100
Ask1.9400 x 100
Day's range1.8000 - 1.8700
52-week range1.6000 - 9.0000
Volume29,181
Avg. volume64,070
Market cap17.45M
Beta (5Y monthly)0.83
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • PR Newswire

    PAVmed Provides Business Update and First Quarter 2024 Financial Results

    PAVmed Inc. (NASDAQ: PAVM, PAVMZ) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating in the medical device, diagnostics, and digital health sectors, today provided a business update for the Company and its subsidiaries, Lucid Diagnostics Inc. (NASDAQ: LUCD) ("Lucid") and Veris Health Inc. ("Veris"), and presented financial results for the Company for the three months ended March 31, 2024.

  • PR Newswire

    Lucid Diagnostics Provides Business Update and First Quarter 2024 Financial Results

    Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ) ( "PAVmed"), today provided a business update for the Company and presented financial results for the three months ended March 31, 2024.

  • PR Newswire

    Legacy Sponge-on-a-String Esophageal Cell Collection Device Subject of Class II FDA Recall

    Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and majority-owned subsidiary of PAVmed Inc. (Nasdaq: PAVM, PAVMZ) ("PAVmed"), announced that the legacy EsophaCap sponge-on-a-string (SOS) esophageal cell collection device, which it briefly supplied to third-party institutions for their own research studies, has been subjected to a Class II FDA recall due to two serious device failures reported in a recent publica